Funding source and the quality of reports of chronic wounds trials: 2004 to 2011

TY - JOUR

T1 - Funding source and the quality of reports of chronic wounds trials

T2 - 2004 to 2011

AU - Hodgson, Robert

AU - Allen, Richard

AU - Broderick, Ellen

AU - Bland, J Martin

AU - Dumville, Jo C

AU - Ashby, Rebecca

AU - Bell-Syer, Sally

AU - Foxlee, Ruth

AU - Hall, Jill

AU - Lamb, Karen

AU - Madden, Mary Teresa

AU - O Meara, Susan

AU - Stubbs, Nikki

AU - Cullum, Nicky

PY - 2014/1/14

Y1 - 2014/1/14

N2 - Critical commentaries suggest that wound care randomised controlled trials (RCTs) are often poorly reported with many methodological flaws. Furthermore, interventions in chronic wounds, rather than being drugs, are often medical devices for which there are no requirements for RCTs to bring products to market. RCTs in wounds trials therefore potentially represent a form of marketing. This study presents a methodological overview of complex wound trials published between 2004 and 2011 and investigates the influence of industry funding on methodological quality.

AB - Critical commentaries suggest that wound care randomised controlled trials (RCTs) are often poorly reported with many methodological flaws. Furthermore, interventions in chronic wounds, rather than being drugs, are often medical devices for which there are no requirements for RCTs to bring products to market. RCTs in wounds trials therefore potentially represent a form of marketing. This study presents a methodological overview of complex wound trials published between 2004 and 2011 and investigates the influence of industry funding on methodological quality.

U2 - 10.1186/1745-6215-15-19

DO - 10.1186/1745-6215-15-19

M3 - Article

C2 - 24422753

SN - 1745-6215

VL - 15

JO - Trials

JF - Trials

IS - 19

ER -